查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2027763

全球心血管外科器械市場：按產品類型、應用、最終用戶、國家和公司分析（2026-2034 年）

Global Cardiovascular Surgical Devices Market Report by Product Type, Application, End User, Countries and Companies Analysis 2026-2034
出版日期: | 出版商: Renub Research | 英文 200 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

心血管外科器械市場規模及預測（2026-2034 年）

全球心血管外科器械市場規模預計將從2025年的27.1億美元成長至2034年的49億美元，2026年至2034年的複合年成長率預計為6.80%。市場成長的主要促進因素包括心血管疾病發生率的上升、微創手術需求的成長以及外科技術的進步。此外，醫療設施的改善和醫療器材應用的普及也是推動市場成長的重要因素。

心血管外科器械市場展望

心血管手術器械是指用於診斷、治療和手術心臟疾病的專用醫療設備。這些器械包括用於心臟瓣膜、支架、移植血管、心律調節器、導管、搭橋手術、置換術術和瓣膜置換等手術的器械。它們有助於改善血液循環、修復心肌組織並恢復心臟功能。由於醫療技術的不斷進步，大多數心血管手術器械現在都能實現微創手術，從而縮短患者的恢復時間。

心血管手術器械市場在全球範圍內需求旺盛，這主要是由於心血管疾病在全球日益普遍，每年奪走許多人的生命。人口老化、不健康的生活方式以及高肥胖率和糖尿病發病率都在推動對心血管外科手術器械的需求。在已開發國家，先進的醫療設備心血管手術器械的使用提供了便利。同時，在開發中國家，醫療產業的蓬勃發展也提高了心血管手術器械的可及性。此外，技術創新和人們對早期治療意識的提高也推動了全球心血管手術器械市場的發展。

心血管外科手術設備市場的成長促進因素

心血管疾病盛行率不斷上升

據估計，2022年全球約有1,980萬人死於心血管疾病（CVD），約佔全球所有死亡人數的32%。其中，85%的死亡與心臟病發作和中風有關。心血管疾病在全球的日益普及是推動心血管外科器械市場成長的主要因素。由於人口老化、久坐的生活方式、不健康的飲食習慣、肥胖以及糖尿病發病率的上升，包括冠狀動脈疾病、心臟衰竭和瓣膜性心臟病在內的心血管疾病的發病率不斷增加。心血管疾病仍然是全球死亡的主要原因之一，因此對治療的需求日益成長。這包括使用各種外科器械，例如支架、心臟瓣膜和搭橋手術。患者數量的增加以及對挽救生命的手術的需求也是推動心血管外科器械市場擴張的重要因素。預計2025年至2050年間，心血管疾病盛行率將增加90.0%，粗死亡率將增加73.4%，粗失能調整後存活年（DALY）增加54.7%。因此，預計到2050年，心血管疾病死亡人數將達到3,560萬人（而2025年為2,050萬人）。

微創和機器人技術的進步

技術進步是推動心血管外科設備產業發展的重要動力之一。隨著微創手術的日益普及，更先進的醫療設備的應用也日益廣泛。微創手術的優點包括縮短住院時間、降低術後併發症風險、加快復原速度、提高病患舒適度。微創手術中使用的醫療設備，例如機器人手術設備和導管系統，正被醫療機構和患者廣泛採用。成像技術和設備的改進也提高了手術的精確度。機器人手術設備能夠幫助外科醫生以最小的切口完成複雜的手術。醫療設備製造商不斷進行研發，致力於將高效率的產品推向市場。 2026年2月，位於阿爾瓦佩特的考維裡醫院（Kauvery Hospital）引入了第四代達文西機器人手術系統，進行了機器人輔助的非體外循環冠狀動脈繞道術，從而擴展了其心率的心臟外科服務。這項措施使考維裡醫院能夠在其心臟護理計畫中引入先進的微創心血管手術服務。

本報告研究了全球心血管外科器械市場，深入分析了成長促進因素和挑戰、細分市場分析以及主要企業分析。

目錄

第1章：引言

第2章：研究與調查方法

第3章摘要整理

第4章 市場動態

  • 成長促進因素
  • 任務

第5章：全球心血管外科器械市場

  • 市場表現
  • 市場預測

第6章 市佔率分析

  • 依產品類型
  • 依用途類型
  • 最終用戶
  • 國家

第7章 產品類型

  • 心臟不停跳手術系統
    • 市場表現
    • 市場預測
  • 心肺體外迴圈裝置
    • 市場表現
    • 市場預測
  • 心導管電氣燒灼術裝置
    • 市場表現
    • 市場預測
  • 灌溉用一次性用品
    • 市場表現
    • 市場預測

第8章 應用

  • 先天性心臟疾病
    • 市場表現
    • 市場預測
  • 心律不整
    • 市場表現
    • 市場預測
  • 心臟疾病
    • 市場表現
    • 市場預測
  • 鬱血性心臟衰竭
    • 市場表現
    • 市場預測
  • 其他
    • 市場表現
    • 市場預測

第9章 最終用戶

  • 醫院
    • 市場表現
    • 市場預測
  • 門診手術中心
    • 市場表現
    • 市場預測
  • 其他
    • 市場表現
    • 市場預測

第10章：國家

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 英國
    • 比利時
    • 荷蘭
    • 土耳其
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 泰國
    • 馬來西亞
    • 印尼
    • 紐西蘭
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第11章：波特五力分析

第12章 SWOT 分析

第13章：主要企業分析

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • Cardinal Health Inc.
  • Medtronic PLC
  • GE Healthcare
  • LivaNova PLC
  • Terumo Corporation
簡介目錄

Cardiovascular Surgical Devices Market Size and Forecast 2026-2034

Cardiovascular Surgical Devices Market will experience growth from USD 2.71 billion in 2025 to USD 4.90 billion by 2034, at a Compound Annual Growth Rate (CAGR) of 6.80% between 2026 and 2034. The market will expand due to the increase in incidences of cardiovascular diseases, rise in the demand for minimally invasive surgery, and improvement in surgical techniques. Moreover, the development of healthcare facilities and increased adoption of medical equipment is adding fuel to the market's growth.

Cardiovascular Surgical Devices Market Outlooks

Heart surgery instruments refer to unique medical equipment used in the detection, treatment, and surgical processes of heart ailments. The devices include heart valves, stents, grafts, pacemakers, catheters, and surgical instruments employed in procedures like bypass surgeries, angioplasties, and valvular replacements. They help in enhancing blood circulation, repairing the heart's tissue, and restoring heart functions. Due to constant developments in medical technologies, most heart surgical devices now facilitate minimally invasive operations, which decrease recovery periods.

The market popularity of heart surgery devices is high across the globe, mainly because cardiovascular ailments are becoming increasingly prevalent worldwide, accounting for numerous deaths annually. Aging demographics, unhealthy living habits, and high obesity and diabetes rates are among the reasons that are promoting the demand for cardiovascular surgical devices. In developed areas, there are well-developed health facilities that provide advanced medical equipment, hence encouraging the use of heart surgery devices. Meanwhile, developing countries are experiencing growth in their healthcare industries and increasing accessibility to heart surgery devices. Besides, technological innovations and enhanced awareness on early treatment are fueling the market for heart surgery devices across the world.

Growth Drivers of the Cardiovascular Surgical Devices Market

Rising Prevalence of Cardiovascular Diseases

The number of people that died due to CVDs was estimated to be 19.8 million in 2022, accounting for around 32% of total deaths worldwide. The majority of these deaths, which amount to 85%, are related to heart attacks and strokes. The increase in the prevalence of cardiovascular diseases (CVDs) around the world is one of the main factors contributing to the growth of the cardiovascular surgery devices market. Coronary artery disease, heart failure, and valve disease, among other CVDs, have seen increased prevalence because of an aging population, a sedentary lifestyle, unhealthy eating habits, obesity, and diabetes cases. Cardiovascular diseases continue to account for most deaths around the world, resulting in high demand for treatment procedures. These include the use of various surgical devices such as stents, heart valves, and bypass grafts. There is also the increasing number of patients and life-saving procedures that are playing a vital role in expanding the cardiovascular surgical devices market. From 2025 through 2050, a 90.0% rise in the prevalence of cardiovascular disease, 73.4% rise in the crude mortality rate, and 54.7% rise in crude DALYs are anticipated, resulting in 35.6 million cardiovascular deaths in 2050 (compared to 20.5 million in 2025).

Advancements in Minimally Invasive and Robotic Technologies

Technological advancement is one of the driving forces behind the evolution of the cardiovascular surgical devices industry. With the growing tendency towards minimally invasive procedures, there has been an increase in the use of surgical devices that have more technological advancements. Some of the advantages associated with minimally invasive procedures include shorter hospital stays, fewer chances of post-surgery complications, quick recovery, and better patient comfort. Surgical devices used in minimally invasive surgeries like robotic devices and catheter systems are increasingly being adopted by both healthcare organizations and patients. Improvements in imaging technology and devices are also contributing to better precision during surgery. Robotic surgery devices are helping surgeons conduct difficult operations while using minimum surgical openings. There has been constant research and development going on by medical device manufacturers to launch efficient products into the market. February 2026: The Kauvery Hospital, located in Alwarpet, has enhanced its services related to advanced cardiac surgery by introducing robotic assisted beating heart coronary artery bypass graft surgery using the 4th Generation da Vinci Robotic Surgical System. Through this initiative, the Kauvery Hospital has been able to introduce an advanced service in minimally invasive cardiac surgery under its heart care program.

Expanding Healthcare Infrastructure and Increasing Healthcare Expenditure

Healthcare infrastructure growth and increasing healthcare spending worldwide are among the primary drivers for the growth of the cardiovascular surgical devices industry. Healthcare organizations are allocating a significant portion of their budget toward establishing new hospital centers, surgery centers, and dedicated cardiac units. They will significantly improve the availability of surgical procedures and sophisticated devices to a broader segment of the population in underdeveloped countries. Higher insurance coverages and reimbursement schemes will increase the affordability of cardiac surgery treatments. In addition, increased focus on quality improvement and achieving better results for patients will encourage the use of innovative surgical devices. Many emerging markets are experiencing a tremendous surge in the development of medical facilities allowing them to treat more patients. Growing medical tourism for heart surgery is further pushing the demand upward. February 2026, the European Commission and the OECD organize a webinar focusing on the release of the release the State of Cardiovascular Health in the European Union, a report published as part of the effort to support the implementation of the European Union's newly adopted Safe Hearts Plan.

Challenges of the Cardiovascular Surgical Devices Market

High Cost of Devices and Surgical Procedures

One of the major obstacles in the market for cardiovascular surgical devices is the costliness involved in implementing the technology and performing the surgery. Robotic-assisted technology, implantable medical devices, and minimal invasive surgical devices involve a considerable amount of money for procurement, training, and maintenance. As a result, the end-users - patients - have to bear the cost of the surgery, thus making the procedure costly for them. This problem is especially serious in low and middle income countries where many people cannot afford expensive surgeries because of their financial status. However, even in highly developed areas, some people can be deterred by the cost of the procedure that is quite steep and has poor insurance coverages. Hospitals and healthcare facilities may also face budget constraints.

Stringent Regulatory Requirements and Product Approval Delays

In this industry, regulatory issues have been known to cause considerable challenges to manufacturers and affect the timely commercialization of innovations. Regulatory bodies require thorough clinical trials, testing and safety procedures to ensure that these devices are safe and effective enough. These regulations are necessary but might lead to the increased duration of the commercialization process. The process of complying with the regulatory requirements differs from one region to another hence making it difficult especially for companies engaged in global businesses. In addition, frequent changes in the regulatory requirements force manufacturers to keep pace with such changes. This presents another challenge, especially to small companies which lack the resources to comply with the regulatory requirements.

Cardiopulmonary Bypass Equipment Devices Market

The market for cardiopulmonary bypass (CPB) devices is a key sector within cardiovascular surgery as these machines take over from the role played by the heart and the lungs while the procedure is being conducted. CPB machines allow surgeons to conduct advanced procedures like open heart surgery, valve surgery, and coronary artery bypass grafting among others with ease and greater accuracy. The prevalence of cardiovascular ailments along with the increase in the number of surgeries is fueling the demand for CPB machines. Technological innovations have contributed to making these machines more efficient, reliable, and safer for use in surgery. There are increased numbers of cardiac centers along with more expertise among surgeons. Moreover, the growth in developing nations is due to the establishment of better healthcare facilities.

Cardiac Ablation Devices Market

There is considerable growth in the market for cardiac ablation devices because of the growing number of cardiac arrhythmia cases and the trend towards opting for minimally invasive procedures. Cardiac ablation devices help in the destruction or isolation of the heart tissues that cause irregularities in heartbeat. The techniques of radiofrequency ablation and cryoablation are common due to their precision and efficiency. The increase in the number of older individuals and those with lifestyle diseases is boosting the need for these procedures. Technical improvements have increased the safety and accuracy of the procedure with better visualization and mapping. Shorter recovery periods and shorter hospital stays are some of the advantages of this procedure.

Cardiac Arrhythmia Devices Market

Cardiac arrhythmia devices market is propelled by the rising requirement for proper diagnosis and management of any kind of irregularities in heartbeats. Some of the common devices used in such treatments include pacemakers, implantable cardioverter defibrillators, and cardiac monitors. These medical tools are vital in ensuring that the patient's heart remains in rhythm to ensure they don't have to go through dangerous situations due to abnormal heart functioning. Increasing cases of arrhythmia, especially amongst the elderly, are fueling the demand for such devices. Technological advancements like small size, wireless capability, and long-lasting batteries are helping make patient experiences more comfortable while improving their treatment results. Moreover, remote monitoring abilities are becoming more common in such devices, enabling health professionals to monitor their patients better and improve their overall recovery chances.

Coronary Heart Disease Devices Market

The market for coronary heart disease (CHD) devices is growing owing to the large number of patients suffering from coronary artery disease, which is one of the major causes of mortality worldwide. Some of the devices that have found use in the treatment of blockages and narrowing of arteries include stents, angioplasty balloons, and coronary guidewires. Growing use of less-invasive procedures, such as PCI (percutaneous coronary intervention), has played a significant role in stimulating demand for CHD devices. Innovation in technologies like drug eluting stents and imaging systems has contributed towards improving treatment outcomes as well. Rising importance being attached to early detection and treatment is motivating people to seek treatment in the initial stages itself. In addition, improvements in healthcare facilities are providing further impetus to the market's growth.

Cardiovascular Surgical Devices Hospitals Market

Hospitals are one of the leading segments within the cardiovascular surgical device market because of their capability to deliver holistic and specific heart care. They are capable of offering advanced surgical machinery, diagnostic machines, and competent health workers needed during complicated cardiovascular procedures. Hospitals cater to diverse kinds of patients, ranging from those that require routine surgery to those who need high-risk surgery. This makes them an essential part of cardiovascular surgical devices. Investments in health infrastructures and the emergence of dedicated heart centers are also bolstering this segment. Furthermore, the presence of intensive care units and post-surgical care increases chances of successful operations. Good reimbursement policies and health insurance coverages motivate people to seek medical assistance in hospitals. With the rising popularity of sophisticated heart surgeries, hospitals will continue to be vital players in the cardiovascular surgical devices market.

United States Cardiovascular Surgical Devices Market

The cardiovascular surgical devices market in the United States is one of the world's most technologically advanced and largest because of substantial investments in healthcare, innovative advancements, and presence of leading medical device manufacturers. The rise in cardiovascular diseases such as coronary heart disease and heart failure drives the demand for cardiovascular procedures such as bypass surgery and valve replacement procedures. The increase in geriatric population adds to the demand for advanced cardiovascular procedures. The favorable reimbursement landscape along with rapid acceptance of novel technologies, including robotic assisted procedures and transcatheter devices, augments market growth. Hospitals and dedicated cardiac centers continue to invest in infrastructure, which adds to the growth in procedure volume. However, stringent regulations and high cost of devices can limit market opportunities. Nevertheless, the market is quite dynamic, with continuous innovations driving future growth. March 2026, Royal Philips, a leading global health technology company, announced its receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance for EchoNavigator R5.0 with DeviceGuide, which is an artificial intelligence-based software application designed to help physicians during one of the toughest interventional cardiology procedures, repair of leaking mitral valves using a minimally invasive approach.

United Kingdom Cardiovascular Surgical Devices Market

The cardiovascular surgical devices market in the United Kingdom is stable, being driven by an efficient public healthcare system and growing awareness about heart disorders. As a result of the rising prevalence of cardiovascular diseases caused by unhealthy habits like obesity and inactivity, patients require more surgery treatment and the use of specialized equipment. The main stakeholder in this market is the National Health Service, which contributes to setting prices and distribution channels. Modern technologies involving minimally invasive surgeries and better image integration become increasingly common to improve the outcomes and speed up patients' recovery process. The government also contributes to expanding the market through the implementation of initiatives aimed at earlier diagnosis and prevention of illnesses. Nevertheless, financial limitations in the healthcare system as well as long approval times hinder the fast uptake of new products. May 2025: Advanced 3D heart scanning launched by the NHS England across the country.

India Cardiovascular Surgical Devices Market

The Indian market for cardiac surgical devices has been registering rapid growth due to increased incidences of heart diseases, increasing healthcare awareness, and improvement in infrastructure facilities within the country. The process of urbanization and changing lifestyles has resulted in a high incidence rate of risk factors, including diabetes and hypertension, which further drives up the number of cardiac surgical operations. The Indian cardiac surgical devices industry has the advantage of an extensive pool of patients along with access to healthcare services within the urban environment. Increasing government efforts through health schemes and insurance have improved accessibility of cardiac surgeries for people. Moreover, the emergence of private hospitals and medical tourism is driving the demand for cardiac surgical devices within the industry. October 2025: Medical technology giant Medtronic plc revealed that the company's latest model of surgical aortic heart valve named Avalus Ultra(TM) Bioprosthesis valve has been introduced in India. Building up on the proven platform of Avalus(TM) which is supported by more than a decade of clinical success, the Avalus Ultra(TM) Bioprosthesis valve has been designed with an objective to provide ease of use during implantation and give a durable circular base and dependable performance for future TAV-in-SAV reinterventions in surgical aortic valves.

Saudi Arabia Cardiovascular Surgical Devices Market

The market for cardiovascular surgical devices in Saudi Arabia is growing steadily due to increased investment in healthcare and the rising incidence of heart diseases caused by changing lifestyles and obesity. The government has set its priorities in line with the Vision 2030 project, which includes upgrading hospitals' infrastructure and making use of innovative technologies in medicine. Cardiovascular surgery device market is fueled by an increased need for surgical interventions including angioplasties, valve replacement operations, and bypass surgeries. Currently, Saudi Arabia heavily depends on imported medical equipment, although there is an effort to stimulate manufacturing of devices within the region. The involvement of private sector players has intensified, thereby promoting healthy competition and improved service levels. June 2025 - Partnership Between Alphaiota & PMcardio Expanded for Launch of First Heart Attack Diagnosis Solution Using Artificial Intelligence in Kingdom of Saudi Arabia PMcardio, an AI-based heart attack diagnosis solution, created by Powerful Medical, a producer of AI-based medical devices for cardiovascular disease diagnoses, was announced to be launched in Kingdom of Saudi Arabia through its distributor, Alphaiota.

Cardiovascular Surgical Devices Market Segments

Product Type

  • Beating Heart Surgery Systems
  • Cardiopulmonary Bypass Equipment
  • Cardiac Ablation Devices
  • Perfusion Disposable

Application

  • Congenital Heart Defects
  • Cardiac Arrhythmia
  • Coronary Heart Disease
  • Congestive Heart Failure
  • Others

End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Regional Market Insights

North America

  • United States
  • Canada

Europe

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom
  • Belgium
  • Netherland
  • Turkey

Asia Pacific

  • China
  • Japan
  • India
  • South Korea
  • Thailand
  • Malaysia
  • Indonesia
  • Australia
  • New Zealand

Latin America

  • Brazil
  • Mexico
  • Argentina

Middle East & Africa

  • Saudi Arabia
  • UAE
  • South Africa

All companies have been covered with 5 Viewpoints

  • Overviews
  • Key Person
  • Recent Developments
  • SWOT Analysis
  • Revenue Analysi

Key Players Analysis

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Edwards Lifesciences
  • Cardinal Health Inc.
  • Medtronic PLC
  • GE Healthcare
  • LivaNova PLC
  • Terumo Corporation

Table of Contents

1. Introduction

2. Research & Methodology

  • 2.1 Data Source
    • 2.1.1 Primary Sources
    • 2.1.2 Secondary Sources
  • 2.2 Research Approach
    • 2.2.1 Top-Down Approach
    • 2.2.2 Bottom-Up Approach
  • 2.3 Forecast Projection Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Cardiovascular Surgical Devices Market

  • 5.1 Historical Market
  • 5.2 Market Forecast

6. Market Share Analysis

  • 6.1 By Product Type
  • 6.2 By Application
  • 6.3 By End User
  • 6.4 By Countries

7. Product Type

  • 7.1 Beating Heart Surgery Systems
    • 7.1.1 Historical Market
    • 7.1.2 Market Forecast
  • 7.2 Cardiopulmonary Bypass Equipment
    • 7.2.1 Historical Market
    • 7.2.2 Market Forecast
  • 7.3 Cardiac Ablation Devices
    • 7.3.1 Historical Market
    • 7.3.2 Market Forecast
  • 7.4 Perfusion Disposable
    • 7.4.1 Historical Market
    • 7.4.2 Market Forecast

8. Application

  • 8.1 Congential Heart Defects
    • 8.1.1 Historical Market
    • 8.1.2 Market Forecast
  • 8.2 Cardiac Arrthymia
    • 8.2.1 Historical Market
    • 8.2.2 Market Forecast
  • 8.3 Coronary Heart Disease
    • 8.3.1 Historical Market
    • 8.3.2 Market Forecast
  • 8.4 Congestive Heart Failure
    • 8.4.1 Historical Market
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Historical Market
    • 8.5.2 Market Forecast

9. End User

  • 9.1 Hospitals
    • 9.1.1 Historical Market
    • 9.1.2 Market Forecast
  • 9.2 Ambulatory Surgical Centers
    • 9.2.1 Historical Market
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Historical Market
    • 9.3.2 Market Forecast

10. Countries

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Historical Market
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Historical Market
      • 10.1.2.2 Market Forecast
  • 10.2 Europe
    • 10.2.1 France
      • 10.2.1.1 Historical Market
      • 10.2.1.2 Market Forecast
    • 10.2.2 Germany
      • 10.2.2.1 Historical Market
      • 10.2.2.2 Market Forecast
    • 10.2.3 Italy
      • 10.2.3.1 Historical Market
      • 10.2.3.2 Market Forecast
    • 10.2.4 Spain
      • 10.2.4.1 Historical Market
      • 10.2.4.2 Market Forecast
    • 10.2.5 United Kingdom
      • 10.2.5.1 Historical Market
      • 10.2.5.2 Market Forecast
    • 10.2.6 Belgium
      • 10.2.6.1 Historical Market
      • 10.2.6.2 Market Forecast
    • 10.2.7 Netherlands
      • 10.2.7.1 Historical Market
      • 10.2.7.2 Market Forecast
    • 10.2.8 Turkey
      • 10.2.8.1 Historical Market
      • 10.2.8.2 Market Forecast
  • 10.3 Asia Pacific
    • 10.3.1 China
      • 10.3.1.1 Historical Market
      • 10.3.1.2 Market Forecast
    • 10.3.2 Japan
      • 10.3.2.1 Historical Market
      • 10.3.2.2 Market Forecast
    • 10.3.3 India
      • 10.3.3.1 Historical Market
      • 10.3.3.2 Market Forecast
    • 10.3.4 Australia
      • 10.3.4.1 Historical Market
      • 10.3.4.2 Market Forecast
    • 10.3.5 South Korea
      • 10.3.5.1 Historical Market
      • 10.3.5.2 Market Forecast
    • 10.3.6 Thailand
      • 10.3.6.1 Historical Market
      • 10.3.6.2 Market Forecast
    • 10.3.7 Malaysia
      • 10.3.7.1 Historical Market
      • 10.3.7.2 Market Forecast
    • 10.3.8 Indonesia
      • 10.3.8.1 Historical Market
      • 10.3.8.2 Market Forecast
    • 10.3.9 New Zealand
      • 10.3.9.1 Historical Market
      • 10.3.9.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Historical Market
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Historical Market
      • 10.4.2.2 Market Forecast
    • 10.4.3 Argentina
      • 10.4.3.1 Historical Market
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East & Africa
    • 10.5.1 South Africa
      • 10.5.1.1 Historical Market
      • 10.5.1.2 Market Forecast
    • 10.5.2 Saudi Arabia
      • 10.5.2.1 Historical Market
      • 10.5.2.2 Market Forecast
    • 10.5.3 UAE
      • 10.5.3.1 Historical Market
      • 10.5.3.2 Market Forecast

11. Porter's Five Forces Analysis

  • 11.1 Bargaining Power of Buyers
  • 11.2 Bargaining Power of Suppliers
  • 11.3 Degree of Competition
  • 11.4 Threat of New Entrants
  • 11.5 Threat of Substitutes

12. SWOT Analysis

  • 12.1 Strength
  • 12.2 Weakness
  • 12.3 Opportunity
  • 12.4 Threats

13. Key Players Analysis

  • 13.1 Abbott Laboratories
    • 13.1.1 Overviews
    • 13.1.2 Key Person
    • 13.1.3 Recent Developments
    • 13.1.4 SWOT Analysis
    • 13.1.5 Revenue Analysis
  • 13.2 Boston Scientific Corporation
    • 13.2.1 Overviews
    • 13.2.2 Key Person
    • 13.2.3 Recent Developments
    • 13.2.4 SWOT Analysis
    • 13.2.5 Revenue Analysis
  • 13.3 Edwards Lifesciences
    • 13.3.1 Overviews
    • 13.3.2 Key Person
    • 13.3.3 Recent Developments
    • 13.3.4 SWOT Analysis
    • 13.3.5 Revenue Analysis
  • 13.4 Cardinal Health Inc.
    • 13.4.1 Overviews
    • 13.4.2 Key Person
    • 13.4.3 Recent Developments
    • 13.4.4 SWOT Analysis
    • 13.4.5 Revenue Analysis
  • 13.5 Medtronic PLC
    • 13.5.1 Overviews
    • 13.5.2 Key Person
    • 13.5.3 Recent Developments
    • 13.5.4 SWOT Analysis
    • 13.5.5 Revenue Analysis
  • 13.6 GE Healthcare
    • 13.6.1 Overviews
    • 13.6.2 Key Person
    • 13.6.3 Recent Developments
    • 13.6.4 SWOT Analysis
    • 13.6.5 Revenue Analysis
  • 13.7 LivaNova PLC
    • 13.7.1 Overviews
    • 13.7.2 Key Person
    • 13.7.3 Recent Developments
    • 13.7.4 SWOT Analysis
    • 13.7.5 Revenue Analysis
  • 13.8 Terumo Corporation
    • 13.8.1 Overviews
    • 13.8.2 Key Person
    • 13.8.3 Recent Developments
    • 13.8.4 SWOT Analysis
    • 13.8.5 Revenue Analysis